Dn B Asset Management As Amgen Inc Transaction History

Dn B Asset Management As

$19.9 Billion
Q2 2024

A detailed history of Dn B Asset Management As transactions in Amgen Inc stock. As of the latest transaction made, Dn B Asset Management As holds 152,124 shares of AMGN stock, worth $48.8 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

152,124

Previous 110,315 37.9%

Holding current value

$48.8 Million

Previous $31.4 Million 51.55%

% of portfolio

0.24%

Previous 0.17%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	BUY	$262.75 - $319.31 $11 Million - $13.4 Million	41,809 Added 37.9%	152,124 $47.5 Million
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $12.8 Million - $15.5 Million	-47,704 Reduced 30.19%	110,315 $31.4 Million
Q4 2023 Jan 04, 2024	BUY	$255.7 - $288.46 $641,551 - $723,746	2,509 Added 1.61%	158,019 $45.5 Million
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $1.96 Million - $2.43 Million	8,944 Added 6.1%	155,510 $41.8 Million
Q2 2023 Jul 06, 2023	BUY	$214.27 - $253.37 $500,748 - $592,125	2,337 Added 1.62%	146,566 $32.5 Million
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $317,460 - $386,931	1,406 Added 0.98%	144,229 $34.9 Million
Q4 2022 Jan 12, 2023	SELL	$229.03 - $291.01 $29,773 - $37,831	-130 Reduced 0.09%	142,823 $37.5 Billion
Q3 2022 Oct 11, 2022	SELL	$224.46 - $253.15 $1 Million - $1.13 Million	-4,462 Reduced 3.03%	142,953 $32.2 Million
Q2 2022 Jul 08, 2022	SELL	$230.71 - $256.74 $464,880 - $517,331	-2,015 Reduced 1.35%	147,415 $35.9 Billion
Q1 2022 Apr 08, 2022	BUY	$219.27 - $242.57 $1.65 Million - $1.83 Million	7,543 Added 5.32%	149,430 $36.1 Million
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $1.6 Million - $1.84 Million	8,067 Added 6.03%	141,887 $31.9 Million
Q3 2021 Oct 15, 2021	BUY	$212.27 - $248.7 $1.78 Million - $2.09 Million	8,396 Added 6.69%	133,820 $28.5 Million
Q2 2021 Jul 06, 2021	BUY	$233.58 - $259.14 $7.2 Million - $7.99 Million	30,845 Added 32.61%	125,424 $30.6 Billion
Q1 2021 Apr 15, 2021	BUY	$221.91 - $258.6 $2.76 Million - $3.21 Million	12,424 Added 15.12%	94,579 $23.5 Million
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $336,470 - $400,676	1,555 Added 1.93%	82,155 $18.9 Million
Q3 2020 Oct 14, 2020	SELL	$234.65 - $260.95 $6.96 Million - $7.74 Million	-29,676 Reduced 26.91%	80,600 $20.5 Million
Q2 2020 Jul 08, 2020	BUY	$197.81 - $242.74 $7.53 Million - $9.23 Million	38,044 Added 52.67%	110,276 $26 Billion
Q1 2020 Apr 17, 2020	SELL	$182.24 - $241.7 $6.76 Million - $8.97 Million	-37,119 Reduced 33.94%	72,232 $14.6 Million
Q4 2019 Jan 13, 2020	BUY	$189.21 - $243.2 $8.05 Million - $10.3 Million	42,544 Added 63.68%	109,351 $26.4 Million
Q3 2019 Oct 16, 2019	BUY	$174.11 - $208.62 $580,308 - $695,330	3,333 Added 5.25%	66,807 $12.9 Million
Q2 2019 Jul 08, 2019	SELL	$166.7 - $195.41 $960,858 - $1.13 Million	-5,764 Reduced 8.32%	63,474 $0
Q1 2019 Apr 11, 2019	SELL	$180.87 - $203.88 $1.32 Million - $1.49 Million	-7,321 Reduced 9.56%	69,238 $0
Q4 2018 Jan 15, 2019	SELL	$178.4 - $208.25 $1.16 Million - $1.36 Million	-6,527 Reduced 7.86%	76,559 $14.9 Million
Q3 2018 Oct 10, 2018	BUY	$185.29 - $208.89 $52,066 - $58,698	281 Added 0.34%	83,086 $0
Q2 2018 Jul 06, 2018	SELL	$166.05 - $186.51 $166,050 - $186,510	-1,000 Reduced 1.19%	82,805 $0
Q1 2018 Apr 11, 2018	BUY	$169.43 - $198.0 $1.2 Million - $1.41 Million	7,100 Added 9.26%	83,805 $0
Q4 2017 Jan 10, 2018	BUY	$168.79 - $188.59 $141,614 - $158,227	839 Added 1.11%	76,705 $0
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $12.7 Million - $14.5 Million	75,866	75,866 $0

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Account

Dn B Asset Management As Amgen Inc Transaction History